Difference between revisions of "Project:Updates Switch Tables"
From Psychiatrienet
(Created page with "=== Updates Switch Tables === ===== March 2022 ===== * Antipsychotics: extended release to extended release switches deleted. * Antipsychotics: oral to different antipsychot...") |
(→March 2024) |
||
| (15 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
=== Updates Switch Tables === | === Updates Switch Tables === | ||
| + | ===== March 2024 ===== | ||
| + | * Antidepressants: Reviewed and updated switches to tranylcypromine, fluoxetine and moclobemide (not finished) | ||
| + | * Updated e-mail: medisch@boom.nl | ||
| + | |||
| + | ===== August 2023 ===== | ||
| + | * Antidepressants: Reviewed and updated switches from and to agomelatine, moclobemide and bupropion (not finished). | ||
| + | |||
| + | ===== June 2023 ===== | ||
| + | * Antidepressants: Reviewed and updated switches from TCA to SSRI and SSRI to TCA (not finished) | ||
| + | |||
| + | ===== February 2023 ===== | ||
| + | * Antidepressants: Reviewed and updated switches from SSRI to SSRI and SSRI to SNRI (not finished) | ||
| + | * Changed reference of literature in switch table | ||
===== March 2022 ===== | ===== March 2022 ===== | ||
| − | * Antipsychotics: | + | * Antipsychotics: Certain long acting to long acting switches deleted. |
| − | * Antipsychotics: oral to different antipsychotic | + | * Antipsychotics: oral to different antipsychotic long acting deleted. |
* Antipsychotics: added penfluridol | * Antipsychotics: added penfluridol | ||
| + | * Antipsychotics: added paliperidone extended release formulations (Xeplion, Trivecta, Byannli) | ||
* Antipsychotics: ziprasidone moved to rest AP | * Antipsychotics: ziprasidone moved to rest AP | ||
* Antipsychotics: paliperidone moved from rest AP | * Antipsychotics: paliperidone moved from rest AP | ||
| Line 11: | Line 25: | ||
===== October 2021 ===== | ===== October 2021 ===== | ||
* Antipsychotics: added group partial antagonists | * Antipsychotics: added group partial antagonists | ||
| + | |||
| + | |||
| + | |||
| + | If you any have suggestions, please send them to info@tijdstroom.nl. We are looking forward to your feedback. | ||
Latest revision as of 11:51, 12 March 2024
Contents
Updates Switch Tables
March 2024
- Antidepressants: Reviewed and updated switches to tranylcypromine, fluoxetine and moclobemide (not finished)
- Updated e-mail: medisch@boom.nl
August 2023
- Antidepressants: Reviewed and updated switches from and to agomelatine, moclobemide and bupropion (not finished).
June 2023
- Antidepressants: Reviewed and updated switches from TCA to SSRI and SSRI to TCA (not finished)
February 2023
- Antidepressants: Reviewed and updated switches from SSRI to SSRI and SSRI to SNRI (not finished)
- Changed reference of literature in switch table
March 2022
- Antipsychotics: Certain long acting to long acting switches deleted.
- Antipsychotics: oral to different antipsychotic long acting deleted.
- Antipsychotics: added penfluridol
- Antipsychotics: added paliperidone extended release formulations (Xeplion, Trivecta, Byannli)
- Antipsychotics: ziprasidone moved to rest AP
- Antipsychotics: paliperidone moved from rest AP
- Introduced Updates Switch Tables page for informing users about changes on the Switchwiki
October 2021
- Antipsychotics: added group partial antagonists
If you any have suggestions, please send them to info@tijdstroom.nl. We are looking forward to your feedback.
